2026 Beauty M&A Predictions with Industry Vet Kimber Maderazzo

Why It Matters

The pivot toward multi‑channel retail and durable consumer appeal reshapes valuation criteria, prompting private equity and strategics to target scalable, retail‑ready beauty brands. Companies that fail to adapt risk being sidelined in a market where large deals set the benchmark.

Key Takeaways

• 2025 saw three billion‑dollar beauty deals, reviving M&A activity.
• Strategic buyers now prioritize omni‑channel retail presence over founder narratives.
• Founder‑led brands risk devaluation without enduring consumer trust.
• PE firms eye Rare Beauty, Kosas, others for 2026 deals.
• Estée Lauder is offloading legacy brands to streamline portfolio.

Pulse Analysis

The 2025 boom in beauty M&A reflects broader private‑equity confidence in consumer‑driven sectors after a period of dormancy. Mega‑cap deals such as e.l.f.’s $1 billion purchase of Rhode and Unilever’s $1.5 billion acquisition of Dr. Squatch signal that strategic buyers are willing to deploy capital at scale when a brand demonstrates robust growth trajectories and clear pathways to market share expansion. This influx of capital also raises the bar for valuation metrics, pushing smaller players to prove they can generate comparable returns.

A decisive trend emerging for 2026 is the emphasis on omni‑channel distribution. Brands that once relied solely on direct‑to‑consumer models are now compelled to secure shelf space at retail powerhouses like Sephora and Ulta, as well as broader e‑commerce platforms. Maderazzo stresses that a consumer‑centric mission—where products are available wherever shoppers prefer to buy—has become a non‑negotiable criterion for acquisition. Retail visibility not only broadens the addressable audience but also provides strategic buyers with tangible data on inventory turnover and brand loyalty across multiple touchpoints.

Founder‑led narratives, while historically valuable for brand storytelling, are losing their strategic weight. Investors are wary of brands whose equity is tied to a single personality, especially when that founder steps back or lacks industry expertise. This shift is prompting portfolio rationalizations, exemplified by Estée Lauder’s decision to offload legacy labels such as Too Faced and Dr. Jart. For emerging brands like Rare Beauty, Kosas, and Starface, aligning with a consumer‑first, multi‑channel strategy will be critical to attract the next wave of M&A interest and secure sustainable growth in a competitive landscape.